81. Sam Mahoney, the CEO of Mahoney Technologies, Inc. (MTI), a biotechnology firm had recently returned
from a conference on modern cost management and performance measurement methods where he was exposed
to target costing, value-chain analysis, balanced scorecard, activity–based management and other ideas.
MTI is a five-year old company operating in a growing, but competitive market. It develops and produces a
number of different enzymes for use by research scientists and pharmaceutical companies. Its main competitors
are also small to medium sized firms just like MTI. The key to growth in this industry is the ability to develop
new products in a short time. Gail Stevenson, the vice-president (VP) for research & development (R&D) has
noticed that some of MTI’s new developments did not perform well because of the delays in their introduction
into the market. Stevenson is very keen on hiring the best scientists and ensuring that they stay current in their
fields because knowledge is the key competitive weapon in the biotechnology industry.
Bob Phillips, the controller of MTI had another concern. He has been noticing that the new products were not
only delayed but their actual development costs were usually higher than budgeted. One of his goals was to see
that the new products were profitable for the company.
Linda Joseph, the production manager, had a different concern of her own. Based on her observation, the
production of the new enzymes was taking longer. Her feeling was that the products spent too much time in the
quality control (QC) department. Barry Laker, the manager of the QC department argued that the new enzymes
lacked the rigorous specifications that are demanded in the marketplace. Consequently, the QC department has
had to perform additional tests to get to the root cause of the problems.
Mahoney had heard complaints from all quarters, and decided to convene a meeting of all the department heads.
Mahoney: Good afternoon, everyone. I am troubled that despite hiring a number of talented scientists, we are
unable to compete effectively in the marketplace. Many of the recent entrants in the game seem to be beating us
easily.
Stevenson: Sam, the key to our growth is rapid introduction of new products. Although my scientists are
developing new enzymes in record times, they seem to be getting held up in manufacturing and especially the
QC department.
Laker: Sam, I think I can pinpoint the root cause of the problem. I agree that our scientists are developing new
enzymes in record times, but they do not seem to be paying any attention to standards. It looks like my
department will have to provide training to them regarding quality control matters.
Stevenson: With due respect, I do not think there is more to know about QC standards. It looks like the
department wants more attention and is therefore creating all this unnecessary fuss.
Joseph: I think I will agree with Barry that there are problems at the R&D side. My production scientists are
also complaining that adequate specifications have not been developed; they have to constantly phone their
R&D counterparts for clarifications.
Stevenson: I do not believe that the production problems can be attributed to R&D) I have personally screened
each and every scientist during the hiring process.
Phillips: I don’t think we will make much progress as a company if we keep pointing fingers at one another. We
all must realize that all problems, regardless of their origin, finally affect the bottom-line of our company.
Unless we set aside our differences and work together as a team, we will be unable to compete with our rivals.
Some of our competitors follow best practices, which we must try to emulate.
Mahoney: I agree with Bob. We must all look for solutions. I recently attended a conference where noted
speakers talked about the value-chain of a company, interrelationships between functions, and the balanced
scorecard. In fact, some speakers suggested that companies must stop discussing in terms of individual
functions or departments; instead they must talk in terms of processes and understand linkages among all the
processes that exist in an organization. I believe there are a number of ideas that we could adopt. I will leave the
conference proceedings in the library, and suggest that we all read about these different topics. How about
getting together after six weeks and discussing a plan of action? Thank you and see you all after six weeks.
Required
Assume the role of a consultant preparing a report for MTI. Discuss the following aspects in your report:
The internal value-chain of MTI
The balanced scorecard. Identify the goals of the company under each perspective of the scorecard and
cause-effect relationships, and develop potential measures that could be used
How the inter-departmental differences can be eliminated